SLC7A11 and lung carcinoma: Recently, more and more studies have reported that SASP-mediated xCT down-regulation results in a variety of tumour suppressive effects in lung cancer (JI et al., 2018), gatric cancer (ZHUANG et al., 2021) and pancreatic cancer (HUNG et al., 2020).